Valiant Laboratories schedules board meeting on May 14, 2026 to approve audited financial results for Q4 and FY ending March 31, 2026.
Trading window closure for insiders remains in effect from March 26, 2026 through May 16, 2026 per insider trading regulations.
Disclosure made under SEBI Listing Regulations Regulation 29 requirements for board meeting intimation.